The effect of bariatric surgery on pharmacotherapy of psychotropic drugs in clinical practice - The effect of bariatric surgery on pharmacotherapy of psychotropic drugs

Sint Antonius Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all
•of the following criteria:, - Indication for bariatric surgery (i.e. Body Mass
•Index (BMI) > 40 kg/m2 or BMI> 35 kg/m2 with additional risk factors) at St
•Antonius hospital. Bariatric surgery includes the following procedures:
•laparoscopic (mini-) gastric bypass or laparoscopic sleeve gastrectomy;
•- Participant >= 18 years, who uses one of de following psychotropic drugs* for
•anxiety and depression;
•- ASA physical classification II or III;
•- Participant is able and willing to sign the Informed Consent form before the
•- Intake and follow up by the Dutch Obesity Clinic (in groups sessions);
•- Participant suffers from psychopathology and uses one of the following
•psychotropic drugs:
•Amitriptyline
•Nortriptyline
•Paroxetine
•Sertraline
•Venlafaxine
•Fluvoxamine
•Fluoxetine
•Citalopram

•A potential subject who meets any of the following criteria will be excluded
•from participation in this study:
•- Known allergy for the administered medicine;
•- Pregnancy or breast-feeding. This is an exclusion criterion for bariatric
•surgery (participants are informed by their surgeon and bariatric nurse). Women
•of childbearing age who use contraceptive methods are allowed to participate in

发起方